ACUTE MYELOID LEUKEMIA, IN RELAPSE
Clinical trials for ACUTE MYELOID LEUKEMIA, IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, IN RELAPSE trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for tough blood cancers in older adults
Disease control TerminatedThis study tested an experimental drug called PF-05212384 for people with aggressive forms of blood cancer, including acute myeloid leukemia (AML) that had returned or didn't respond to other treatments, or AML that developed as a side effect of prior cancer therapy. The goal was…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New cell therapy tested in kids with aggressive leukemia
Disease control TerminatedThis early-phase study tested a new cell therapy called CART123 in children and young adults (ages 1-29) whose acute myeloid leukemia (AML) had returned or did not respond to standard treatments. Doctors collected and genetically modified the patient's own immune cells (T cells) …
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC